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Introduction: The development of various benign oral mucosal lesions associated with dental implants, such as
pyogenic granuloma or peripheral giant cell granuloma, has been rarely reported. However, the occurrence of
vascular diseases, such as hemangioma, related to dental implants has not been explored in the literature. In this
study, we report a case of co-development of pyogenic granuloma and capillary hemangioma on the alveolar ridge
associated with a dental implant in a patient undergoing antithrombotic therapy. To the best of our knowledge,
this is first case of hemangioma formation associated with a dental implant.
Case presentation: A 68-year-old Korean man was referred for intermittent bleeding and a dome-shaped
overgrowing mass on his upper alveolar ridge. He underwent dental implantation 5 years ago, and was started on
warfarin for cerebral infarction a year ago. He had experienced gum bleeding and gingival mass formation 6 months
after warfarinization; then, his implant fixture was removed. However, his gingival mass has been gradually increasing.
The gingival mass was surgically excised, and revealed the coexistence of pyogenic granuloma and capillary
hemangioma in histological analysis of the specimen. The lesion has showed no recurrence for more than a year.
Conclusions: Regarding immunostaining features, the endothelial cell markers, CD34 and CD31, and the mesenchymal
cell marker, vimentin, were strongly detected, but cell proliferation marker, Ki-67, was negatively expressed in the
endothelial cells of the hemangioma portion. However, in the pyogenic granuloma portion, CD34 was almost
negatively detected, whereas vimentin and Ki-67 were highly detected in the fibroblast-like tumor cells. According to
these heterogeneous characteristics of the lesion, the patient was diagnosed with coexistence of pyogenic granuloma
and capillary hemangioma associated with the dental implant on the attached gingiva. We recommend that patients
with dental implants who have chronic peri-implantitis under antithrombotic therapy should be closely followed to
ensure early detection of oral mucosal abnormalities.
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Dental implantation has become one of the most com-
mon dental procedures. However, some serious compli-
cations related to dental implant placement, including
hemorrhage and life-threatening swelling, have occasion-
ally been reported [1]. In addition, the unexpected deve-
lopment of benign mucosal diseases, such as pyogenic* Correspondence: parkbw@gnu.ac.kr
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unless otherwise stated.granuloma (PG) or peripheral giant cell granuloma, that
are associated with dental implants has been reported in
several cases [2-6]. The etiology of these mucosal dis-
eases related with dental implants has not been deter-
mined; however, chronic irritation due to corrosion of
the fixture surface and chronic inflammation may be
considered contributing factors to their pathogenesis [3].
In medically compromised patients, some unpredicted
complications can be caused by simple dental proce-
dures, such as tooth extraction or dental implant place-
ment. In particular, antithrombotic therapy could induced. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the development of any vascular disease, including he-
mangioma or vascular malformation, in patients under-
going antithrombotic therapy has not been explored in
the literature. Hemangioma is a benign tumor of vascular
endothelial cells, characterized by the benign prolifer-
ation of blood vessels, and is the most common type
of childhood tumor [7,8]. This particular vascular dis-
ease has also not been reported in relation with den-
tal implant procedures.
In this study, we report a case of co-development of
PG and capillary hemangioma in the upper alveolar ridge
associated with a dental implant in a warfarinized patient.
To confirm the characteristics of the lesion, the excised
specimen was immunohistochemically analyzed with var-
ious antibodies for markers of endothelial cells, mes-
enchymal cells and cell proliferation. To the best of our
knowledge, this is first case of hemangioma formation as-
sociated with a dental implant in a medically compro-
mised patient.
Case presentation
A 68-year-old Korean man was referred by his dentist
for intermittent bleeding and a dome-shaped overgrow-
ing mass on his upper left alveolar ridge (Figure 1A). He
underwent dental implantation on his upper first mo-
lar site 5 years ago, and regular curettage has been
done for the treatment of recurrence of peri-implantitis
(Figures 1D and 1E). Four years after his dental implant-
ation, he had a cerebral infarction and was started on
antithrombotic therapy with warfarin by a neurologist.Figure 1 Preoperative clinical and magnetic resonance imaging views
(A) A firm and round dome-shaped mass was observed in the site of the p
resonance imaging, a 1.5cm heterogeneous mass was observed on the att
and 4 years (E) after fixture placement. (E) Progressive alveolar bone destructi
(F) Panorama at the first visit to our clinic, 5 months after fixture removal. TheAfter 6 months of warfarinization, he experienced inter-
mittent gum bleeding and an overgrowing gingival mass
in the implant site. Thus, the implant was removed by
his dentist for fixture mobility at 5 months before visiting
our clinic. However, the gingival mass has been gradually
increasing, and spontaneous gingival bleeding was en-
countered, even after the removal of the implant fixture.
An intra-oral examination of the patient revealed a
firm dome-shaped mass on his upper left alveolar ridge,
which is the site of previous implantation. Although the
center of the lesion was bluish, which was probably due
to discoloration from occlusion trauma, other parts of the
mass showed a pink-colored smooth surface (Figure 1A).
Magnetic resonance imaging showed a 1.5cm round non-
homogeneous lesion on his upper left alveolar ridge,
which was most probably a benign vascular neoplasm
(Figure 1B and C). The lesion was surgically excised under
local anesthesia, and complete coagulation on the surgical
bed was obtained with electrocauterization.
Histology of the specimen revealed an ulcerated nod-
ule and edematous granulation tissues under the epithe-
lium of the tumor with numerous small blood vessels
and neutrophil infiltration. The patient was diagnosed
with PG (Figures 2A and 2B). The deeper part of the le-
sion showed numerous newly developed vessels filled
with thrombi and their communications with delicate fi-
brillar connective tissues, indicating capillary hemangioma
(Figures 2A, 2C and 2D). To confirm the characteristics of
the tumor, the slides were immunostained with specific
marker antibodies for endothelial cells, mesenchymal cells,
and cell proliferation. For immunohistochemical analysis,(A-C) and follow-up panoramic views for implantation (D-F).
revious implant, the left maxillary first molar. (B and C) In magnetic
ached gingiva (arrows). (D and E) Panoramic views at 3 months (D)
on due to peri-implantitis was observed at 4 years after implantation.
re is no associated bony defect with the gingival mass.
Figure 2 Hematoxylin and eosin staining features of specimen. (A) Tumor specimen at low magnification. Asterisk (*) indicates the pyogenic
granuloma portion of the lesion, and arrows show the development of capillary hemangioma and thrombosis. (B) The pyogenic granuloma
portion at higher magnification. Edematous granulation tissues and numerous small blood vessels with neutrophil infiltration were observed
under the epithelium of the tumor. (C and D) Capillary hemangioma portion of the tumor at higher magnification showing numerous newly
generated blood vessels filled with thrombi. Newly developed capillary vessels were seen to communicate with each other and lined with a thin
endothelial cell layer. Scale bar = 200μm.
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into 4μm sections and mounted on glass slides. The sec-
tions were maintained at room temperature for 12 hours
and deparaffinized. After hydration, immunohistoche-
mical staining was conducted using an automated immu-
nostainer (BenchMark XT, Ventana Medical Systems Inc.,
Tucson, AZ, USA). The primary antibodies used and im-
munohistochemical staining results are summarized in
Table 1.
Regarding immunostaining features, vascular endothe-
lial cell and hematopoietic progenitor markers, CD31
and CD34, were strongly expressed in neovascularized
endothelial cells of the hemangioma portion. However,
in PG, CD31 was highly detected in the small blood ves-
sels of the tumor, whereas CD34 was rarely expressed.Table 1 Primary antibodies and their dilution rate, and
result of semi-quantitative analysis for immunostaining
intensity
Antibody Dilution Source Immunostaining intensity
Hemangioma PG
CD34 1:3000 Neomarkers +++ –
CD31 1:20 Dako +++ ++
Vimentin 1:20 Dako +++ +++
Ki-67 1:2000 Dako – ++
Abbreviations: CD31, Cluster of differentiation 31 (platelet endothelial cell
adhesion molecule); CD34, Cluster of differentiation 34; Ki-67, MKI67; PG,
pyogenic granuloma. Positive immunostaining intensities were graded as +++,
++, + and – for strong, moderate, weak and negative staining, respectively.The mesenchymal cell marker, vimentin, was strongly
detected in both hemangioma and PG portions. The cell
proliferation marker, Ki-67, was almost negative in the
hemangioma portion, but it was moderately expressed
in the fibroblast-like tumor cells of the PG portion
(Figure 3). According to these heterogeneous charac-
teristics of the lesion, the patient was diagnosed with
coexistence of PG and capillary hemangioma associ-
ated with the dental implant on the attached gingiva.
The lesion has showed no recurrence or bleeding for
more than a year.
Discussion
The causes of reactive peri-implant mucosal diseases have
not been completely understood. One putative cause is
the corrosion of the fixture surface and metal particles [3].
In addition, chronic mucosal inflammation resulting from
poor oral hygiene or trauma from mobilized suprastruc-
ture of the implant could be considered contributing fac-
tors for peri-implant mucosal diseases [2,9]. It is well
known that inflammatory cells facilitate the initial steps of
tumorigenesis or, alternatively, inflammatory cells could
be coopted by neoplastic cells during tumor progression
[10,11]. In the present case, chronic inflammation due to
recurrent peri-implantitis could be considered one of the
contributing factors to the development of PG in the peri-
implant gingival tissue.
Hemangioma is one of the most common tumors in
neonates and children, and is classified into capillary and
Figure 3 Immunohistochemical analysis for the markers of endothelial cells, mesenchymal cells and cell proliferation in the specimen.
In the hemangioma portion of the lesion, the endothelial cell markers, CD34 and CD31, and the mesenchymal cell marker, vimentin, were strongly
observed, but the cell proliferating marker, Ki-67, was negatively expressed in the newly developed vascular vessels. However, in the PG portion, CD34
was almost negatively detected, whereas vimentin and Ki-67 were highly detected in the fibroblast-like tumor cells. Scale bar = 100μm. CD31, Cluster
of differentiation 31 (platelet endothelial cell adhesion molecule); CD34, Cluster of differentiation 34; Ki-67, MKI67; PG, pyogenic granuloma.
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ces and histology. Capillary hemangioma is characterized
by numerous proliferating small thin-walled blood-filled
vessels composed of a single layer of endothelial cells,
surrounded by a discontinuous layer of pericytes and re-
ticular fibers, and by its uncommonness in older aged
people [7,8]. However, the occurrence of capillary he-
mangioma related to dental implants or antithrombotic
therapy has not been explained in the literature. On the
contrary, antithrombotic therapy with heparin or warfarin
has been used as complementary therapy in patients withcancer because of its anti-angiogenic property in tumors,
which results in the interference of tumor cell prolifera-
tion and metastasis processes [12-14]. These actions are
mainly done by the binding of antithrombotic agents to
angiogenic growth factors, such as fibroblast growth fac-
tors and vascular endothelial growth factors, which inhibit
angiogenesis [12]. However, the most common side effect
of warfarin is hemorrhage, even though the risk of life-
threatening severe bleeding is not large. Interestingly, he-
morrhage shows a relatively higher frequency in the gum
or nose than in other organs [15]. In addition, the risk of
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tiplatelet drugs or nonsteroidal anti-inflammatory drugs
[16], or in elderly patients [17].
In this report, the patient had used the prosthesis after
implantation for 4.5 years, and undertaken antithrom-
botic therapy with warfarin for a year. He felt an abnormal
gingival mass formation and spontaneous gum bleeding
starting 6 months after warfarinization. Interestingly, the
gingival mass showed two different entities, PG and capil-
lary hemangioma, in terms of its histological features. In
the immunohistochemistry of the hemangioma portion of
the lesion, hematopoietic markers, CD31 and CD34, were
highly detected in neogenerated vascular tissues, whereas
the cell proliferating marker, Ki-67, was negatively de-
tected in the endothelial cells of the hemangioma. How-
ever, almost negative expression of CD34 but strongly
detected Ki-67 was observed in the PG portion. The me-
senchymal cell marker, vimentin, was strongly detected
in both endothelial cells of the hemangioma and fibro-
blasts in the PG portion. The results of the immunohis-
tochemical analysis of the present case indicate that these
histomorphologically different entities possess different
properties and have developed coincidentally in one gin-
gival mass.Conclusions
Although a direct relationship between hemangioma de-
velopment and warfarinization could not be established
in this case, frequent bleeding due to antithrombotic
therapy and chronic inflammation of peri-implantitis are
suspected to be causally associated with the develop-
ment of neovascularization as well as PG in the gum tis-
sue. Chronic irritation, including inflammation of peri-
implantitis, could generate various neoplasms in the oral
mucosa [18,19]. To the best of our knowledge, this is the
first case of co-development of PG and capillary hema-
ngioma in the attached gingiva associated with a dental
implant in a medically compromised patient. We recom-
mend that patients with dental implants who have chronic
peri-implantitis under antithrombotic therapy should be
closely followed to ensure early detection of oral mu-
cosal abnormalities. In addition, it is advisable to report all
clinical cases of lesions associated with dental implants
in order to contribute information that will help to de-
termine the etiology, pathogenesis, and course of these
lesions.Consent
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